Your shopping cart is currently empty

ATM-IN-2 is a selective, orally active ATM inhibitor with an IC50 of 4 nM. It demonstrates high kinase selectivity, being over 700 times more selective relative to PIKK family members. ATM-IN-2 exerts its anti-tumor effects and promotes apoptosis by inhibiting ATM phosphorylation and downstream signaling pathways (p53, H2AX). It is applicable for research in solid tumors, such as colon cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | ATM-IN-2 is a selective, orally active ATM inhibitor with an IC50 of 4 nM. It demonstrates high kinase selectivity, being over 700 times more selective relative to PIKK family members. ATM-IN-2 exerts its anti-tumor effects and promotes apoptosis by inhibiting ATM phosphorylation and downstream signaling pathways (p53, H2AX). It is applicable for research in solid tumors, such as colon cancer. |
| Targets&IC50 | ATM:4 nM |
| In vitro | ATM-IN-2 (Compound 25a) demonstrates potent inhibitory activity against HEL116 and SW620 cells over 6-7 days with IC50 values of 58.2 and 66.6 nM, respectively, significantly reducing the cells' clonogenic potential. Over a 2-day period, ATM-IN-2 (1-4 μM) enhances the therapeutic effect of Irinotecan by exacerbating G2/M phase arrest and promoting apoptosis, leading to a synergistic antiproliferative effect in HCT116 cells. Additionally, ATM-IN-2 (0.25-2 μM, 4 h) effectively suppresses ATM signaling activation in HCT116 and SW620 cells. |
| In vivo | ATM-IN-2 (Compound 25a), administered orally at doses of 15-30 mg/kg for 14-20 days, exhibits synergistic anti-tumor activity with Irinotecan in a mouse xenograft cancer model. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.